Stopping GLP-1 treatment: what withdrawal trials show
What semaglutide and tirzepatide withdrawal trials show about regain, why their designs differ, and how to plan maintenance with a care team.
Search explainers, questions, and medicine profiles.
Every published article, newest first. Reporting, explainers, and practical guides on weight and metabolic health.
What semaglutide and tirzepatide withdrawal trials show about regain, why their designs differ, and how to plan maintenance with a care team.
Choose an activity metric that answers your question: steps can describe walking volume, while minutes can include intensity and non-walking activity.
Restart movement with a realistic baseline, symptom awareness and a repeatable first step instead of trying to recreate your old routine.
Evaluate a smart scale by separating weight measurement from estimated body composition, then checking validation, usability, costs and privacy.
Build a weight-management plan around sleep opportunities, food access and rotating shifts, with meal-timing evidence kept in its proper context.
What SURMOUNT-5 shows about semaglutide and tirzepatide, and how doses, diabetes status and approved uses limit the comparison.
Build meals around nourishment, preference and practical preparation, and use satisfaction as information rather than a test of willpower.
Read the September 2026 TRIUMPH-1 retatrutide results, their population and analysis limits, and the confirmed US investigational status.
Make restaurant decisions around enjoyment, appetite and practical choices, without compensating for one meal or relying on perfect calorie information.